Cargando…
Crucial Role of TSC-22 in Preventing the Proteasomal Degradation of p53 in Cervical Cancer
The p53 tumor suppressor function can be compromised in many tumors by the cellular antagonist HDM2 and human papillomavirus oncogene E6 that induce p53 degradation. Restoration of p53 activity has strong therapeutic potential. Here, we identified TSC-22 as a novel p53-interacting protein and show i...
Autores principales: | Yoon, Cheol-Hee, Rho, Seung Bae, Kim, Seong-Tae, Kho, Seongho, Park, Junsoo, Jang, Ik-Soon, Woo, Seonock, Kim, Sung Soon, Lee, Je-Ho, Lee, Seung-Hoon |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3411576/ https://www.ncbi.nlm.nih.gov/pubmed/22870275 http://dx.doi.org/10.1371/journal.pone.0042006 |
Ejemplares similares
-
TSC-22 inhibits CSF-1R function and induces apoptosis in cervical cancer
por: Cho, Min-Ji, et al.
Publicado: (2017) -
SUMOylation-mediated PSME3-20S proteasomal degradation of transcription factor CP2c is crucial for cell cycle progression
por: Son, Seung Han, et al.
Publicado: (2023) -
Ell3 stabilizes p53 following CDDP treatment via its effects on ubiquitin-dependent and -independent proteasomal degradation pathways in breast cancer cells
por: Ahn, Hee-Jin, et al.
Publicado: (2015) -
NQO1 inhibits proteasome-mediated degradation of HIF-1α
por: Oh, Eun-Taex, et al.
Publicado: (2016) -
Transforming Stimulated Clone 22 (TSC-22) Interacts Directly with
Bromodomain-Containing Protein 7 (BRD7) to Enhance the Inhibition of
Extracellular Signal-Regulate Kinase (ERK) Pathway in Ovarian
Cancer
por: Lee, Seung-Hoon, et al.
Publicado: (2022)